Skip to main content
Premium Trial:

Request an Annual Quote

Asper Biotech

Premium
Asper Biotech launched two arrays this month. The first is a chip for screening six genes connected with hereditary breast and ovarian cancer.
 
The company said the array enables users to analyze 88 mutations in the BRCA1, BRCA2, CHEK2, RAD51, NBN, and CASP8 genes.
 

Asper also launched an array for Wilson disease screening that assays 104 mutations in the ATP7B gene. The Wilson disease chip was developed and validated with the University of Brno in the Czech Republic, Asper said.

The Scan

Booster Push

New data shows a decline in SARS-CoV-2 vaccine efficacy over time, which the New York Times says Pfizer is using to argue its case for a booster, even as the lower efficacy remains high.

With Help from Mr. Fluffington, PurrhD

Cats could make good study animals for genetic research, the University of Missouri's Leslie Lyons tells the Atlantic.

Man Charged With Threatening to Harm Fauci, Collins

The Hill reports that Thomas Patrick Connally, Jr., was charged with making threats against federal officials.

Nature Papers Present Approach to Find Natural Products, Method to ID Cancer Driver Mutations, More

In Nature this week: combination of cryogenic electron microscopy with genome mining helps uncover natural products, driver mutations in cancer, and more.